US Drug Recall Register
Class I · High risk Terminated Initiated Jul 1, 2014 (12 years ago)

Oxcarbazepine Tablets

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544.

What was recalled

Oxcarbazepine Tablets, 300 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 62584-143-01

Recalling firm
American Health Packaging
NDC code
62584-143-01
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1590-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pine recalls

See all
Class II · Moderate risk Ongoing

Amlodipine and Olmesartan Medoxomil Tablets

Reason Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

Ascend Laboratories, LLC D-0712-2026
Class II · Moderate risk Ongoing

Cleviprex

Reason Lack of Assurance of Sterility

Chiesi USA, Inc. NDC 10122-611-10 D-0689-2026
Class III · Low risk Ongoing

Epinephrine Injection

Reason Failed Impurities/Degradations Specifications

Fresenius Kabi USA, LLC NDC 63323-696-02 D-0581-2026
Class II · Moderate risk Ongoing

Amlodipine and Olmesartan Medoxomil Tablets

Reason Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications

Ascend Laboratories, LLC NDC 67877-501-30 D-0556-2026
Class II · Moderate risk Ongoing

EPINEPHRINE Injection

Reason Lack of Assurance of Sterility

International Medication Systems Ltd. NDC 76329-3318-1 D-0483-2026